Related Experiment Video
Updated: May 3, 2026
05:17
Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
59.8K
Intravenous drug delivery in neonates: lessons learnt
Catherine M T Sherwin1, Natalie J Medlicott2, David M Reith3
1Division of Clinical Pharmacology & Clinical Trials Office, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Archives of Disease in Childhood
|February 1, 2014
Summary
Administering intravenous drugs to neonates is challenging due to infusion system variables. Understanding these factors is crucial for accurate drug delivery and patient safety.
Area of Science:
- Neonatal pharmacology
- Pediatric drug delivery
- Intravenous infusion systems
Background:
- Neonatal intravenous drug administration faces unique challenges.
- These include slow flow rates, small volumes, and "dead space" in infusion lines.
- Existing knowledge of neonatal pharmacokinetics often overlooks infusion delivery variability.
Purpose of the Study:
- To explore physical variables affecting drug passage through neonatal intravenous lines.
- To improve understanding of drug delivery kinetics in neonates.
- To identify causes of delayed drug delivery and optimize administration protocols.
Main Methods:
- Investigating physical variables impacting drug transit in neonatal IV lines.
- Analyzing factors contributing to delayed drug delivery.
- Exploring modifications to administration protocols.
Main Results:
- Significant delays and variability in intravenous drug delivery were observed.
- Physical characteristics of neonatal infusion systems contribute to these issues.
- Accurate pharmacokinetic and pharmacodynamic assessments are hindered.
Conclusions:
- Further research into physical variables is essential for neonatal drug administration.
- Optimizing infusion protocols can ensure predictable drug delivery.
- Improved understanding enhances patient safety and therapeutic outcomes.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
01:29Drug Dosing: Infants and Children
1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
01:29Drug Delivery: Parenteral Route
2.8K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
2.8K
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
554
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
208
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
208
01:21Intrauterine Drug Delivery Systems
168
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
168